Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
124.95B
Market cap124.95B
Price-Earnings ratio
13.71
Price-Earnings ratio13.71
Dividend yield
4.03%
Dividend yield4.03%
Average volume
12.69M
Average volume12.69M
High today
$62.65
High today$62.65
Low today
$61.08
Low today$61.08
Open price
$62.36
Open price$62.36
Volume
15.84M
Volume15.84M
52 Week high
$68.64
52 Week high$68.64
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $61.29, giving the company a market capitalization of 124.95B. It carries a P/E multiple of 13.71 and pays a dividend yield of 4.03%.

On 2026-09-24, Bristol-Myers Squibb(BMY) stock moved within a range of $61.08 to $62.65. With shares now at $61.29, the stock is trading +0.4% above its intraday low and -2.2% below the session's peak.

Trading volume for Bristol-Myers Squibb(BMY) stock has reached 15.84M, versus its average volume of 12.69M.

The stock's 52-week range extends from a low of $42.52 to a high of $68.64.

The stock's 52-week range extends from a low of $42.52 to a high of $68.64.

BMY News

MarketWatch 12h
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors - MarketWatch

...

Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Nasdaq 6d
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Key Points AbbVie continues to diversify its revenue streams with successful expansions in immunology and aesthetics. Bristol-Myers Squibb maintains high net...

AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Analyst ratings

58%

of 31 ratings
Buy
35.5%
Hold
58.1%
Sell
6.5%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.